JNK signalling in cancer: in need of new, smarter therapeutic targets

Bubici, C and Papa, S orcid.org/0000-0002-8369-6538 (2014) JNK signalling in cancer: in need of new, smarter therapeutic targets. British Journal of Pharmacology, 171 (1). pp. 24-37. ISSN 0007-1188

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2013 The British Pharmacological Society. This is the peer reviewed version of the following article: Bubici, C. and Papa, S. (2014), JNK signalling in cancer: in need of new, smarter therapeutic targets. British Journal of Pharmacology, 171: 24–37; which has been published in final form at https://dx.doi.org/10.1111/bph.12432. This article may be used for non-commercial purposes in accordance with the Wiley Terms and Conditions for Self-Archiving.
Keywords: JNK1; JNK2; PARP14; survival; apoptosis; multiple myeloma; hepatocellular carcinoma; cancer targets
Dates:
  • Published (online): 10 December 2013
  • Published: January 2014
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 07 Jul 2016 13:53
Last Modified: 17 Jan 2018 16:37
Published Version: https://dx.doi.org/10.1111/bph.12432
Status: Published
Publisher: Wiley: 12 months
Identification Number: https://doi.org/10.1111/bph.12432
Related URLs:

Share / Export

Statistics